-
Catalpol: Designing Causal Neuroinflammation Assays
2026-09-18
Catalpol, also known as Catalpinoside, offers a useful framework for connecting behavioral phenotypes with oxidative stress, NLRP3 inflammasome activity, and microglial signaling. This article translates a key CUMS-mouse study into practical assay decisions while distinguishing validated evidence from broader disease-model applications.
-
Alternariol (AOH): Mechanisms and Research Workflow
2026-09-18
Alternariol, also called AOH, is an emerging Alternaria mycotoxin used to study CYP metabolism, apoptosis, cytoskeletal injury, and hepatic stellate-cell activation. Current evidence supports controlled in vitro mechanistic research, but it does not establish that AOH exposure alone causes human liver fibrosis.
-
Linagliptin (BI-1356): A DPP-4 Assay Guide
2026-09-17
Linagliptin (BI-1356) is best interpreted through DPP-4 target engagement, not as a substitute for NUAK inhibition in tau studies. This guide connects rigorous assay design with findings from human and mouse brain tissue research while defining the limits of cross-pathway interpretation.
-
Angiotensin 1/2 (2-7) in Reliable Cell Assays
2026-09-17
This scenario-based guide explains how Angiotensin 1/2 (2-7), SKU A1050, can support controlled cell viability, proliferation, cytotoxicity, and renin–angiotensin signaling experiments. It connects peptide identity, solvent selection, storage, assay controls, and literature interpretation to practical laboratory decisions.
-
Cy5 Hydrazide for Nanoparticle Interaction Mapping
2026-09-16
Cy5 hydrazide is a carbonyl-reactive fluorescent dye that can help distinguish nanoparticle association from biomolecular oxidation. This article develops an assay-design framework linking FAST nutraceutical formulations with redox-sensitive fluorescence while clarifying controls, labeling targets, and interpretation limits.
-
NLRP10 and Epidermal Barrier Function in AD
2026-09-15
The reference study identifies NLRP10 as an epidermal homeostasis factor that supports keratinocyte survival, p63-dependent differentiation, and barrier integrity. Its findings connect reduced NLRP10 expression in atopic dermatitis with caspase-8-mediated cell death and impaired epidermal maturation, providing a mechanistic basis for further barrier-focused research.
-
NHS-Biotin for Nanobody and Protein Assays
2026-09-15
NHS-Biotin enables practical, amine-selective labeling for antibody assays, intracellular studies, and streptavidin-based purification. This guide connects its established chemistry with peptidisc-assisted nanobody clustering while separating demonstrated findings from assay recommendations.
-
Quantifying Methylated Purine Nucleosides by UHPLC–MS/MS
2026-09-14
The reference study develops a stable isotope-diluted UHPLC–ESI-MS/MS workflow for resolving and quantifying methylated purine nucleosides, including 1-methyladenosine (1-methyl Ado), in cellular samples. Its combination of ammonium bicarbonate-enhanced ionization, isomer-resolving chromatography, methanol extraction, and solid-phase extraction improves sensitivity and reduces matrix interference for RNA modification research and biomarker discovery.
-
VE-821: ATR Inhibition Beyond Canonical DDR
2026-09-14
VE-821 offers a selective way to interrogate ATR-dependent checkpoint signaling, radiosensitization, and chemotherapy sensitization. This thought-leadership analysis connects ATR biology with emerging epigenetic insights from human bocavirus research while clearly separating established evidence from translational hypotheses.
-
ANP Research: From Natriuresis to Translation
2026-09-13
A mechanism-led guide to using rat Atrial Natriuretic Peptide in cardiovascular, renal, and translational research while distinguishing established physiology from exploratory cross-domain hypotheses.
-
MLKL–Lysosome Signaling in Necroptosis
2026-09-12
The reference study identifies MLKL polymerization-induced lysosomal membrane permeabilization as a critical execution step in necroptosis, linking lysosomal rupture to cytosolic cathepsin B activity. Its imaging, genetic, and pharmacological experiments provide a framework for testing lysosomal protease involvement in regulated cell death.
-
2-Deoxy-D-glucose: Metabolic Assay Workflows
2026-09-12
Turn 2-Deoxy-D-glucose into a controlled metabolic perturbation rather than a single endpoint reagent. This guide connects glycolysis inhibition in cancer research, viral replication studies, and Wnt-linked osteoblast assays with practical dosing, controls, and troubleshooting strategies.
-
Olsalazine Sodium Research Workflows
2026-09-11
Olsalazine Sodium connects macrophage inflammation assays with colorectal cancer tumor model research through a water-based formulation and clearly defined mechanistic readouts. This guide shows how to build dose-response, apoptosis, chemotaxis, and xenobiotic-clearance workflows while avoiding solvent and stability-related artifacts.
-
EZ Cap Cy5 Firefly Luciferase mRNA Guide
2026-09-11
This scenario-driven guide explains how EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP), SKU R1010, can help distinguish mRNA delivery from productive translation in cell viability, proliferation, and cytotoxicity workflows. It combines practical handling guidance with quantitative literature context for more defensible reporter-assay interpretation.
-
DNP-Induced seRNA Drives NPC Metastasis
2026-09-10
The 2023 study identifies a carcinogen-responsive super-enhancer RNA, seRNA-NPCm, as an active regulator of nasopharyngeal carcinoma metastasis. Its data connect DNP exposure to super-enhancer looping, NPM1/c-Myc recruitment, and NDRG1 transcription, providing a mechanistic framework for studying environmentally induced metastatic programs.